Use of Antimalarial Agents is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus.
antimalarial agents
health perceptions
health-related quality of life
medication adherence
patient-reported outcomes
systemic lupus erythematosus
treatment
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
10 Jun 2020
10 Jun 2020
Historique:
received:
14
05
2020
revised:
05
06
2020
accepted:
08
06
2020
entrez:
14
6
2020
pubmed:
14
6
2020
medline:
14
6
2020
Statut:
epublish
Résumé
Impaired health-related quality of life (HRQoL) is a major problem in patients with systemic lupus erythematosus (SLE). Antimalarial agents (AMA) are the cornerstone of SLE therapy, but data on their impact on HRQoL are scarce. We investigated this impact using baseline data from the BLISS-52 (NCT00424476) and BLISS-76 (NCT00410384) trials (
Identifiants
pubmed: 32532059
pii: jcm9061813
doi: 10.3390/jcm9061813
pmc: PMC7355692
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : GlaxoSmithKline
ID : PSS-212673-Karolinska-ISS-SA
Organisme : Reumatikerförbundet
ID : R-932236
Organisme : Stiftelsen Professor Nanna Svartz Fond
ID : 2019-00290
Organisme : Ulla and Roland Gustafsson Foundation
ID : 2019-12
Organisme : Stockholms Läns Landsting
ID : -
Organisme : Karolinska Institutet
ID : -
Références
J Am Acad Dermatol. 2011 Dec;65(6):e179-93
pubmed: 20739095
Lupus. 2018 Mar;27(3):501-506
pubmed: 28764617
Patient Relat Outcome Meas. 2019 Jan 09;10:1-7
pubmed: 30666173
Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):221-33
pubmed: 24625040
Med Care. 2005 Mar;43(3):203-20
pubmed: 15725977
Ann Rheum Dis. 2007 Jun;66(6):821-4
pubmed: 17324970
Lupus. 2018 Feb;27(2):257-264
pubmed: 28728507
Lupus. 2013 Oct;22(11):1118-27
pubmed: 23989737
Arthritis Rheum. 2007 Aug 15;57(6):972-9
pubmed: 17665467
Lupus. 1996 Jun;5 Suppl 1:S16-22
pubmed: 8803905
Ann Rheum Dis. 2014 May;73(5):838-44
pubmed: 23524886
Lupus. 2016 Sep;25(10):1111-21
pubmed: 27497256
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S413-9
pubmed: 22588761
N Engl J Med. 2005 Dec 15;353(24):2550-8
pubmed: 16354891
Ann Rheum Dis. 2019 Jun;78(6):736-745
pubmed: 30926722
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9
pubmed: 11124729
Nat Rev Nephrol. 2011 Oct 18;7(12):718-29
pubmed: 22009248
Arthritis Care Res (Hoboken). 2019 Jun;71(6):811-821
pubmed: 30055091
Eur Heart J. 2014 Aug 7;35(30):2001-9
pubmed: 24904027
Lancet. 2019 Jun 8;393(10188):2332-2343
pubmed: 31180030
Ann Rheum Dis. 2007 Sep;66(9):1168-72
pubmed: 17389655
Lupus. 2010 Dec;19(14):1606-13
pubmed: 20829309
Nat Rev Dis Primers. 2016 Jun 16;2:16039
pubmed: 27306639
Blood. 2008 Sep 1;112(5):1687-95
pubmed: 18577708
Lupus. 2018 May;27(6):913-919
pubmed: 29301472
Lancet. 2011 Feb 26;377(9767):721-31
pubmed: 21296403
Ann Rheum Dis. 2017 Mar;76(3):554-561
pubmed: 27884822
BMC Musculoskelet Disord. 2015 Aug 12;16:188
pubmed: 26264937
Arthritis Rheum. 1996 Mar;39(3):363-9
pubmed: 8607884
Lupus. 2019 Feb;28(2):163-173
pubmed: 30580659
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Lupus. 2016 Jun;25(7):735-40
pubmed: 26876692
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Arthritis Rheum. 2011 Dec;63(12):3918-30
pubmed: 22127708
Arthritis Rheum. 2004 Jun 15;51(3):465-74
pubmed: 15188335
Lupus. 2018 Feb;27(2):265-272
pubmed: 28659047
Expert Rev Pharmacoecon Outcomes Res. 2005 Jun;5(3):317-26
pubmed: 19807601
Health Qual Life Outcomes. 2003 Dec 16;1:79
pubmed: 14678568
Lupus. 2018 Sep;27(10):1652-1660
pubmed: 30020020
Lupus. 2006;15(9):577-83
pubmed: 17080912
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Q J Med. 1993 Jul;86(7):447-58
pubmed: 8210301